Association of Inflammatory and Metabolic Biomarkers with Lifestyle-Related Diseases in the Community Population

Inflammatory and Metabolic Biomarkers in Lifestyle-Related Diseases

Authors

  • Amina Tassadaq Department of Medicine, Punjab Medical College, Faisalabad, Punjab, Pakistan Author
  • Arooj Tassadaq Department of Physiology, Sharif Medical and Dental College, Lahore, Punjab, Pakistan Author
  • Nazish Jamil Associate Professor, Department of Physiology, Sharif Medical and Dental College, Lahore, Punjab, Pakistan Author

DOI:

https://doi.org/10.69750/dmls.03.04.0204

Keywords:

Inflammatory biomarkers, Metabolic syndrome, hs-CRP, Lifestyle diseases, Dyslipidemia, Cardiometabolic risk

Abstract

Background: Chronic inflammation and metabolic dysfunction are closely linked to lifestyle-related diseases such as obesity, hypertension, diabetes mellitus, dyslipidemia, and metabolic syndrome, which are rapidly rising all over the world. Inflammatory and metabolic markers can be useful to identify early those who are at greater cardiometabolic risk.

Objective: To assess the relationship between inflammatory and metabolic biomarkers and lifestyle-related diseases in the community.

Methods: This cross-sectional community-based study was conducted from March 2023 to September 2025 at the Department of Medicine, Punjab Medical College, Faisalabad, Pakistan, and Sharif Medical and Dental College, Lahore, Pakistan. A total of 200 participants aged 20–70 years were enrolled using non-probability consecutive sampling. Structured questionnaires were used to collect anthropometric measurements and lifestyle-related data. The blood samples were used to determine high-sensitivity C-reactive protein (hs-CRP), fasting blood glucose, glycated hemoglobin (HbA1c), lipid profile, and serum uric acid.

Results: Among 200 participants, 112 (56.0%) were females, and 88 (44.0%) were males. Obesity was observed in 39.5%, hypertension in 36.5%, diabetes mellitus in 30.5%, dyslipidemia in 46.0%, and metabolic syndrome in 34.0% of participants. Mean hs-CRP levels were significantly higher among diseased participants (6.1 ± 1.7 mg/L) compared to healthy individuals (2.2 ± 0.8 mg/L; p<0.001). In addition, the HbA1c, triglycerides, LDL-C, fasting blood glucose, and serum uric acid levels were also significantly increased among individuals with lifestyle-related diseases. A high level of hs-CRP was most strongly and independently associated with metabolic syndrome.

Conclusion: There is a strong correlation between inflammatory and metabolic markers and lifestyle-related diseases, and they can be useful markers for early recognition of cardiometabolic diseases.

Downloads

Download data is not yet available.

References

Ferreira LDNM, Fisberg RM, Sarti FM, Rogero MM. Association between inflammatory and metabolic biomarkers and common mental disorders among adults: 2015 Health Survey of São Paulo, SP, Brazil. Metabolites. 2024;14(10):535. doi:10.3390/metabo14100535.

Kuring JK, Mathias JL, Ward L, Tachas G. Inflammatory markers in persons with clinically significant depression, anxiety, or PTSD: a systematic review and meta-analysis. J Psychiatr Res. 2023;168:279-292. doi:10.1016/j.jpsychires.2023.10.009.

Thylur DS, Goldsmith DR. Brick by brick: building a transdiagnostic understanding of inflammation in psychiatry. Harv Rev Psychiatry. 2022;30:40-53. doi:10.1097/HRP.0000000000000326.

Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci. 2019;1437:57-67. doi:10.1111/nyas.13712.

Angiulli F, Conti E, Zoia CP, Da Re F, Appollonio I, Ferrarese C, et al. Blood-based biomarkers of neuroinflammation in Alzheimer’s disease: a central role for periphery? Diagnostics (Basel). 2021;11:1525. doi:10.3390/diagnostics11091525.

Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22-34. doi:10.1038/nri.2015.5.

Hasheminasabgorji E, Jha JC. Dyslipidemia, diabetes, and atherosclerosis: role of inflammation and ROS-redox-sensitive factors. Biomedicines. 2021;9:1602. doi:10.3390/biomedicines9111602.

Hotamisligil GS. Inflammation, metaflammation, and immunometabolic disorders. Nature. 2017;542:177-185. doi:10.1038/nature21363.

Stein DJ, Benjet C, Gureje O, Lund C, Scott KM, Poznyak V, et al. Integrating mental health with other non-communicable diseases. BMJ. 2019;364:l295. doi:10.1136/bmj.l295.

Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645. doi:10.1161/CIRCULATIONAHA.109.192644.

Lin S, Pan J, Zhu X, Lan R, Sun X, Shen R, et al. Associations of metabolic indicators and inflammation-related indices with adverse cardiovascular events in US adults: NHANES 1999-2018. Lipids Health Dis. 2026;25(1):57. doi:10.1186/s12944-026-02866-w.

Tian X, Chen S, Zuo Y, Zhang Y, Zhang X, Xu Q, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident cardiovascular disease. BMC Med. 2022;20(1):383. doi:10.1186/s12916-022-02592-x.

Šebeková K, Staruchová M, Mišľanová C, Líšková A, Horváthová M, Tulinská J, et al. Association of inflammatory and oxidative status markers with metabolic syndrome and its components in 40-to-45-year-old females: a cross-sectional study. Antioxidants (Basel). 2023;12(6):1221. doi:10.3390/antiox12061221.

Cho SMJ, Lee H, Shim JS, Jeon JY, Kim HC. Association between physical activity and inflammatory markers in community-dwelling, middle-aged adults. Appl Physiol Nutr Metab. 2021;46(7):828-836. doi:10.1139/apnm-2020-1069.

Dehghani Firouzabadi F, Jayedi A, Asgari E, Akbarzadeh Z, Janbozorgi N, Djafarian K, et al. Association of dietary and lifestyle inflammation score with metabolic syndrome in a sample of Iranian adults. Front Nutr. 2021;8:735174. doi:10.3389/fnut.2021.735174.

Dugani SB, Moorthy MV, Li C, Demler OV, Alsheikh-Ali AA, Ridker PM, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiol. 2021;6(4):437-447. doi:10.1001/jamacardio.2020.7073.

Carrasco-Marín F, Zhao L, Hébert JR, Wirth MD, Petermann-Rocha F, Phillips N, et al. Association of a dietary inflammatory index with cardiometabolic, endocrine, liver, renal, and bone biomarkers: cross-sectional analysis of the UK Biobank study. Nutr Metab Cardiovasc Dis. 2024;34(7):1731-1740. doi:10.1016/j.numecd.2024.03.010.

Farmanfarma KK, Kaykhaei MA, Adineh HA, Mohammadi M, Dabiri S, Ansari-Moghaddam A. Prevalence of metabolic syndrome in Iran: a meta-analysis of 69 studies. Diabetes Metab Syndr. 2019;13:792-799. doi:10.1016/j.dsx.2018.11.055.

Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bulló M, Couture P, Covas MI, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. Nutr Rev. 2017;75:307-326. doi:10.1093/nutrit/nux014.

Zhu Z, Wu F, Lu Y, Wu C, Wang Z, Zang J, et al. Total and nonheme dietary iron intake is associated with metabolic syndrome and its components in Chinese men and women. Nutrients. 2018;10:1663. doi:10.3390/nu10111663.

Downloads

Crossmark - Check for Updates PlumX Metrics

Published

30-04-2026

How to Cite

Tassadaq, A., Tassadaq, A., & Jamil, N. (2026). Association of Inflammatory and Metabolic Biomarkers with Lifestyle-Related Diseases in the Community Population: Inflammatory and Metabolic Biomarkers in Lifestyle-Related Diseases. DEVELOPMENTAL MEDICO-LIFE-SCIENCES, 3(4), 10-15. https://doi.org/10.69750/dmls.03.04.0204

Share